Showing results (1951-1960 of 2,190) with videos related to
Sort By:
Pageof 219
Journal for Immunotherapy of Cancer|June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumorsAsha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.Cellular and Molecular Gastroenterology and Hepatology|March 3, 2023
Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast ModelVelina S Atanasova, Crhistian de Jesus Cardona, Václav Hejret, et al.Psychological Medicine|September 8, 2023
Long-term effects of electroconvulsive therapy on brain structure in major depressionTiana Borgers, Verena Enneking, Melissa Klug, et al.Biological Psychiatry|April 7, 2023
Negative Stressful Life Events and Social Support Are Associated With White Matter Integrity in Depressed Patients and Healthy Control Participants: A Diffusion Tensor Imaging StudyKira Flinkenflügel, Susanne Meinert, Katharina Thiel, et al.ACS Chemical Biology|February 11, 2025
Workflow for E3 Ligase Ligand Validation for PROTAC DevelopmentNebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 15, 2025
Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorderFlorian Thomas-Odenthal, Lea Teutenberg, Frederike Stein, et al.Bone Marrow Transplantation|June 14, 2024
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantationNormann Steiner, Radwan Massoud, Evgeny Klyuchnikov, et al.Beilstein Journal of Nanotechnology|June 24, 2016
Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detectionDinusha N Udukala, Hongwang Wang, Sebastian O Wendel, et al.Neoplasma|November 24, 2021
Establishment of PANDA - a new human pancreatic ductal adenocarcinoma cell line with 3D cell culture technologyRomana Zahumenska, Michal Kalman, Juraj Marcinek, et al.Nature Communications|December 9, 2025
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumorsMichael Launspach, Julia Macos, Shoaib Afzal, et al.Pageof 219